Dark Forest Capital Management’s Cullinan Oncology CGEM Stock Holding History

Dark Forest Capital Management’s Portfolio CGEM Stock Details CGEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-10,214	Closed	-$158K	–	1327
2021 Q4	$158K	Sell	10,214 -15,195	-60%	-$303K	0.06%	269
2021 Q3	$573K	Buy	25,409 +11,237	+79%	+$300K	0.2%	107
2021 Q2	$365K	Buy	+14,172	New	+$436K	0.16%	61

Other funds holding CGEM

MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

AIG

American International Group New York $609M AUM 23.67% 1-Year Est. Return

Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return

Dark Forest Capital Management's CGEM Position: Q1 2022 in Review

Dark Forest Capital Management sold out of Cullinan Oncology (CGEM) in Q1 2022, closing a stake of 10,214 shares — an estimated $158K sold.

Dark Forest Capital Management first reported a position in CGEM in Q2 2021 and held it in 3 quarters. The position peaked at $573K in Q3 2021. 82 funds tracked by Wall St. Rank hold CGEM as of Q1 2022.

Dark Forest Capital Management reported no remaining Cullinan Oncology position as of Q1 2022 after selling out during the quarter.
Dark Forest Capital Management sold 10,214 Cullinan Oncology shares in Q1 2022, an estimated $158K.
Dark Forest Capital Management first reported a position in Cullinan Oncology in Q2 2021 and held it in 3 quarters.
Dark Forest Capital Management's Cullinan Oncology position peaked at $573K in Q3 2021.
82 funds tracked by Wall St. Rank held Cullinan Oncology as of Q1 2022.

Based on Dark Forest Capital Management's 13F filing for Q1 2022, filed 13 May 2022.